Aclaris Therapeutics (ACRS) Stock Chart & Stock Price History $1.57 +0.02 (+1.29%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$1.54 -0.03 (-1.59%) As of 08/7/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aclaris Therapeutics Stock Price Performance The Aclaris Therapeutics (ACRS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 34.19%, with a year-to-date return of -36.69%. In the past month, the stock has increased 8.28%, reflecting recent market activity. As of the latest close, Aclaris Therapeutics traded at $1.57 with a market cap of $170 million and volume of 608,330 shares. Five years ago, the stock traded at $2.10, representing a 25.24% decrease over that period. At the time, it had a market cap of $77.23 million and a volume of 467,141 shares. Receive ACRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.61%1 Month Performance+8.28%3 Month Performance+19.85%Year-To-Date Performance-36.69%1 Year Performance+34.19%5 Year Performance-25.24% ACRS Stock Chart for Friday, August, 8, 2025 ACRS Chart by TradingView Aclaris Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025$1.55$1.57+1.29%$1.58$1.52608,330 shs$170 million08/06/2025$1.55$1.55$1.58$1.52716,019 shs$167.84 million08/05/2025$1.56$1.55-0.64%$1.60$1.53415,584 shs$167.83 million08/04/2025$1.53$1.56+1.96%$1.56$1.50663,275 shs$168.92 million08/01/2025$1.53$1.53$1.59$1.501.09 million shs$165.67 million07/31/2025$1.53$1.53$1.56$1.461.27 million shs$165.67 million07/30/2025$1.55$1.53-1.29%$1.86$1.506.33 million shs$165.67 million07/29/2025$1.68$1.55-7.74%$1.71$1.546.67 million shs$167.83 million07/28/2025$1.70$1.68-1.18%$1.76$1.64840,814 shs$181.91 million07/25/2025$1.68$1.70+1.19%$1.72$1.67441,182 shs$184.08 million Get the Latest News and Ratings for ACRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025$1.68$1.68$1.78$1.641.38 million shs$181.91 million07/23/2025$1.62$1.68+3.70%$1.68$1.62345,746 shs$181.91 million07/22/2025$1.64$1.62-1.22%$1.70$1.62555,759 shs$175.42 million07/21/2025$1.61$1.64+1.86%$1.78$1.611.21 million shs$177.58 million07/18/2025$1.59$1.61+1.26%$1.63$1.58650,344 shs$174.33 million07/17/2025$1.58$1.59+0.63%$1.63$1.56549,795 shs$172.17 million07/16/2025$1.52$1.58+3.95%$1.58$1.51507,657 shs$171.08 million07/15/2025$1.58$1.52-3.80%$1.60$1.52556,503 shs$164.59 million07/14/2025$1.57$1.58+0.64%$1.68$1.56902,887 shs$171.08 million07/11/2025$1.59$1.57-1.26%$1.61$1.54585,136 shs$170 million07/10/2025$1.54$1.59+3.25%$1.63$1.541.27 million shs$172.17 million07/09/2025$1.45$1.54+6.21%$1.57$1.44622,965 shs$166.75 million07/08/2025$1.46$1.45-0.68%$1.50$1.45576,608 shs$157.01 million07/07/2025$1.45$1.46+1.04%$1.50$1.44567,998 shs$158.09 million Related Companies Dianthus Therapeutics Stock Chart KalVista Pharmaceuticals Stock Chart Maze Therapeutics Stock Chart ArriVent BioPharma Stock Chart Mind Medicine (MindMed) Stock Chart Arbutus Biopharma Stock Chart Autolus Therapeutics Stock Chart Gyre Therapeutics Stock Chart MeiraGTx Stock Chart Valneva Stock Chart Receive ACRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ACRS) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclaris Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclaris Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
